Core Insights - The Shanghai Gaobo Cancer Hospital, located in the Shanghai Free Trade Zone, has prescribed Capivasertib to a patient, marking the first prescription of this drug in Shanghai since its approval by the National Medical Products Administration in April 2023 [1] - As the first research-oriented hospital in the Shanghai Free Trade Zone, the Shanghai Gaobo Cancer Hospital has successfully facilitated the launch of seven innovative drugs since its establishment [1] - The hospital is currently conducting 40 clinical trials for new drugs and has prescribed multiple "global new" medications in addition to Capivasertib [1]